Results 151 to 160 of about 4,906 (168)

Association of adipocytokine pathway gene polymorphisms with NAFLD in obese children. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Wang J, Pan X, Wei J, Li X, Zhou H, Xu N, Kang R, Zhong Y, Luo J.   +8 more
europepmc   +1 more source

[Impact of arsenic exposure on the hepatic metabolic molecular network in obese pregnant mice using metabolomics and proteomics]. [PDF]

Se Pu
Cai LJ, Wang Y, Tan JF, Zhou HX, Liang SJ, Wu Y, Zhang J.   +6 more
europepmc   +1 more source

Correlation between obesity and early vascular aging in middle-aged and young adult health check-up populations. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Zhao L, Cui M, Li Y, Li Y, Miao R, Wang J, Zhou H.   +6 more
europepmc   +1 more source

[Reoxygenation improves reduced hypothalamic leptin responsiveness induced by intermittent hypoxia in obese rats]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Dong M, Zhu T, Ma J, DU X, Feng Y.
europepmc   +1 more source

An Aboriginal-driven program to prevent, control and manage nutrition-related 'lifestyle' diseases including diabetes [PDF]

, 2006
Bridge, Ernie, Davis, Elizabeth A, Gracey, Michael, Jones, Timothy, Martin, David, Shephard, Mark Douglas, Spargo, Randolph M   +6 more
core  

Association of whole blood copper, zinc, calcium, magnesium, and iron with non-alcoholic fatty liver disease in overweight and obese children. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Huang Z, Luo M, Dai W, Yao Z, Ouyang S, Xu N, Zhou H, Li X, Zhong Y, Luo J.   +9 more
europepmc   +1 more source

[Synthetic phenolic compounds perturb lipid metabolism and induce obesogenic effects]. [PDF]

Se Pu
Liu HN, Sun ZD, Liu Q, Zhou QF, Jiang GB.   +4 more
europepmc   +1 more source

EGR3 reduces podocyte inflammatory damage in obesity related glomerulopathy by inhibiting the PRMT1/p-STAT3 pathway. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Peng L, Sun X, Yi X, Wang Z, Chen K.
europepmc   +1 more source

[Triglyceride-glucose index in non-obese individuals: its association with and predictive value for non-alcoholic fatty liver disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Xiao J, Li Y, Fang M, Gong H, Li W, Zhang C, Chen F, Zhang Y, Han T.   +8 more
europepmc   +1 more source